Technology
Health
Medical
Cytosorbents
$4.809876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (0.63%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Cytosorbents and other stocks, options, ETFs, and crypto commission-free!
About CTSO
CytoSorbents Corp. engages in the research and development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product include CytoSorb, ContrastSorb, HemoDefend, VetResQ, and DrugSorb. Read More The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.
Employees
125
Headquarters
Monmouth Junction, New Jersey
Founded
2002
Market Cap
155.05M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
431.29K
High Today
$4.87
Low Today
$4.34
Open Price
$4.85
Volume
306.55K
52 Week High
$14.95
52 Week Low
$3.68
Collections
Technology
Health
Medical
Research And Development
US
North America
Price Paid on Robinhood
37% Lower
Right Now
52 Week Low
$6.70
Average Price Paid
$7.61
52 Week High
$14.95
CTSO Earnings
-$0.19
-$0.16
-$0.12
-$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.14 per share
Actual
-$0.11 per share